226 related articles for article (PubMed ID: 37382415)
1. BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1.
Wang P; Sun J; Sun C; Zhao H; Zhang Y; Chen J
Cancer Biol Ther; 2023 Dec; 24(1):2225884. PubMed ID: 37382415
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
Shang R; Pu M; Li Y; Wang D
Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
6. Basic Transcription Factor 3 Is Required for Proliferation and Epithelial-Mesenchymal Transition via Regulation of FOXM1 and JAK2/STAT3 Signaling in Gastric Cancer.
Zhang DZ; Chen BH; Zhang LF; Cheng MK; Fang XJ; Wu XJ
Oncol Res; 2017 Nov; 25(9):1453-1462. PubMed ID: 28276310
[TBL] [Abstract][Full Text] [Related]
7. circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma.
Chen W; Li Y; Zhong J; Wen G
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880589
[TBL] [Abstract][Full Text] [Related]
8. Propofol disrupts cell carcinogenesis and aerobic glycolysis by regulating circTADA2A/miR-455-3p/FOXM1 axis in lung cancer.
Zhao H; Wei H; He J; Wang D; Li W; Wang Y; Ai Y; Yang J
Cell Cycle; 2020 Oct; 19(19):2538-2552. PubMed ID: 32857667
[TBL] [Abstract][Full Text] [Related]
9. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
10. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
[TBL] [Abstract][Full Text] [Related]
11. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
12. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
[TBL] [Abstract][Full Text] [Related]
13. [LncRNA HULC promots HCC growth by downregulating miR-29].
Zhu LR; Feng JL; Liu XJ; Wang JM
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
[No Abstract] [Full Text] [Related]
14. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
Amann T; Maegdefrau U; Hartmann A; Agaimy A; Marienhagen J; Weiss TS; Stoeltzing O; Warnecke C; Schölmerich J; Oefner PJ; Kreutz M; Bosserhoff AK; Hellerbrand C
Am J Pathol; 2009 Apr; 174(4):1544-52. PubMed ID: 19286567
[TBL] [Abstract][Full Text] [Related]
15. Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8
Gao Y; Gong Y; Lu J; Yang Y; Zhang Y; Xiong Y; Shi X
Biochem Pharmacol; 2024 Jul; 225():116294. PubMed ID: 38754557
[TBL] [Abstract][Full Text] [Related]
16. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
17. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
[TBL] [Abstract][Full Text] [Related]
18. Astragaloside IV inhibits cell viability and glycolysis of hepatocellular carcinoma by regulating KAT2A-mediated succinylation of PGAM1.
Zhu Y; Lu F
BMC Cancer; 2024 Jun; 24(1):682. PubMed ID: 38835015
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus increases the anti-cancer effect of Huai Er by regulating hypoxia inducible factor-1α-mediated glycolysis in hepatocellular carcinoma.
Zhou L; Zhao Y; Pan LC; Wang J; Shi XJ; Du GS; He Q
World J Gastroenterol; 2022 Aug; 28(32):4600-4619. PubMed ID: 36157928
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA circDENND4C facilitates proliferation, migration and glycolysis of colorectal cancer cells through miR-760/GLUT1 axis.
Zhang ZJ; Zhang YH; Qin XJ; Wang YX; Fu J
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2387-2400. PubMed ID: 32196590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]